Nepsilon-Benzyloxycarbonyl-Nalpha-Boc-L-lysine N-succinimidyl ester, 95%
Nepsilon-Benzyloxycarbonyl-Nalpha-Boc-L-lysine N-succinimidyl ester, 95%
Nepsilon-Benzyloxycarbonyl-Nalpha-Boc-L-lysine N-succinimidyl ester, 95%
Thermo Scientific Chemicals

Nepsilon-Benzyloxycarbonyl-Nalpha-Boc-L-lysine N-succinimidyl ester, 95%

CAS: 34404-36-9 | C23H31N3O8 | 477.51 g/mol
製品番号(カタログ番号) H63470.06
または、製品番号H63470-06
価格(JPY)
-
数量:
5 g
一括またはカスタム形式をリクエストする
化学物質識別子
CAS34404-36-9
IUPAC Name2,5-dioxopyrrolidin-1-yl (2S)-6-{[(benzyloxy)carbonyl]amino}-2-{[(tert-butoxy)carbonyl]amino}hexanoate
Molecular FormulaC23H31N3O8
InChI KeyYWLICOCXPNQJPC-AGDOHHJYNA-N
SMILESCC(C)(C)OC(=O)N[C@@H](CCCCNC(=O)OCC1=CC=CC=C1)C(=O)ON1C(=O)CCC1=O
さらに表示
FormPowder
Appearance (Color)White
Assay (HPLC)>94.0%
Nepsilon-Benzyloxycarbonyl-Nalpha-Boc-L-lysine N-succinimidyl ester is a reactant involved in Cellular labeling and tumor MRI as a bimodal lipidic contrast agent, Synthesis of improved peptide prodrugs 5-ALA for photodynamic therapy, Design of high affinity peptide conjugates as markers for small peptide transporter PEPT1 (SLC15A1), Preparation of human growth hormone derivatives containing PEG groups, Enantiodivergent asymmetric cyclization and Solid-phase synthesis of peptide-cationic steroid conjugates for antibacterial screening.

This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

Solubility
Slightly soluble in water.

Notes
Store in freezer at(-20°C). Keep container tightly closed. Store away from oxidizing agent.
RUO – Research Use Only

General References:

  1. Nazila Kamaly; Tammy Kalber; Gavin Kenny; Jimmy Bell; Michael Jorgensen; Andrew Miller. A novel bimodal lipidic contrast agent for cellular labelling and tumour MRI. Organic & Biomolecular Chemistry. 2010, 8(1), 201-211.
  2. Francesca Giuntini; Ludovic Bourré; Alexander J MacRobert; Michael Wilson; Ian M Eggleston. Improved peptide prodrugs of 5-ALA for PDT: rationalization of cellular accumulation and protoporphyrin IX production by direct determination of cellular prodrug uptake and prodrug metabolization. Journal of medicinal and pharmaceutical chemistry. 2009, 52(13), 4026-4037.